Alexander Gregory R. reported grant involving 368,458 derivative units of Syra Health Corp at $0.00 for $0 on Aug 31, 2026

Grant
Form 4 code A. Grant, award, or other acquisition under Rule 16b-3(d).
CEO
CEO
Filed Sep 28, 2026

Facts from the filing

Form 4/A · Derivative, table II
Disclosed value
$0Shares × reported price
Shares traded
368,458Performance Stock Units
Price per share
$0.00Reported price. Read footnotes for ranges.
% of reported position traded
UnavailableThis security and ownership context
Holdings after
368,458Direct
Trade date
Aug 31, 2026Grant
Filed
Sep 28, 2026, 4:35 PM ET28-day reporting delay
Accession
0001493152-26-044577Code A · Transaction 230442
How reported position traded is calculated

Not calculated for derivative securities.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

No other transaction rows in this filing.

1 transaction row in this filing. Joint filers share the same rows.

This amendment is separate from the original filing. It may contain only changed rows. Read both SEC reports.

Filing warnings

Notes recorded with this filing
2 warnings
amended filingThis transaction comes from an amended Form 4 filing.
delayed filingThe filing was reported 28 calendar days after the transaction date.

SYRA price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
SYRA · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.

Return windows are pending. The first 7-day window is eligible on Oct 5, 2026. Values appear when the daily price refresh supplies a valid close for that window. Weekends, market holidays and missing prices can delay updates.

Pre-filing1mo ago 0%1w ago 0%1d ago 0%
Returns since7d30d90d180d1y

Footnotes in full

F1: 20% of the Performance Stock Units vest one year after date of grant and the remainder vest upon the achievement of certain company financial metrics.